Cargando…
Use of natural cysteine protease inhibitors in limiting SARS-Co-2 fusion into human respiratory cells
Specific antibodies that humans acquire as a result of disease or after vaccination are needed to effectively suppress infection with a specific variant of SARS CoV-2 virus. The S protein of the D614G variant of coronavirus is used as an antigen in known vaccines to date. It is known that COVID-19 d...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598048/ https://www.ncbi.nlm.nih.gov/pubmed/36313266 http://dx.doi.org/10.1016/j.mehy.2022.110965 |